Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
2006/07/07 by R. R. Griffiths, Roland R. Griffiths, W. A. Richards +4 · 1,694 citations
Pharmacology, Toxicology and Pharmaceutics · Psychology · #Anxiety #Clinical psychology #Forensic Toxicology and Drug Analysis #Hallucinogen #Paranormal Experiences and Beliefs #Perception #Psilocybin #Psychedelics and Drug Studies #Psychiatry #Psychology
paper · doi:10.1007/s00213-006-0457-5
published in Psychopharmacology 187(3), 268-283 (Springer Science+Business Media)
openalex publication_date 2006/07/07 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Citations
Cited by
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- Existential feelings as a phenomenological framework for psychedelic therapy
- Mushroom poisoning: A proposed new clinical classification
- Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation
- Dissolving yourself in connection to others: shared experiences of ego attenuation and connectedness during group VR experiences can be comparable to psychedelics
- Experiencing timelessness and the phenomenology of temporal flow
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- Psychedelics and autobiographical memory – six open questions
- The study of mystical experiences and Latour’s ontological turn: toward a participatory approach
- Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
- Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models
- Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms
- From self-transcendent emotions to transcendent experiences: an exploratory study in the continuity between everyday and mystical experiences
- Realization experiences: a convergent account of insight and mystical experiences
- A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience
- Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
- Understanding mystical experiences through the lens of entropy: introduction to the special issue on ‘mystical entropy’
- Psychedelic Mystical Experiences Are Authentic
- The role of self-transcendent emotions in psychedelic experiences: a two-process proposal
- Conceptualizing Psychedelic Pure Consciousness
- Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
- Learning from Boundlessness: Psychedelic induced awe and epistemic shifts towards a holistic worldview
- Fostering Wonder Through the Arts and Humanities: Using Visual Thinking Strategies in Medical Education
- DMT-Induced Shifts in Criticality Correlate with Self-Dissolution
- Fearful symmetry in altered states: a bi-logic account of psychedelic action
- Harm potential of magic mushroom use: A review
- Natural language analysis of the structure of altered states of consciousness
- A qualitative analysis of the psychedelic mushroom come-up and come-down
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
- Observational cohort study of a group-based VR program to improve mental health and wellbeing in people with life-threatening illnesses
- Global species diversity and distribution of the psychedelic fungal genus Panaeolus
- Harm reduction practises for users of psychedelic drugs: a scoping review
- Psychedelics beyond medicine: Treatment, enhancement, hype, consent, and the limits of medicalization
- Analyzing the concept of independence in psychedelic research
- Phenomenology, Structure, and Dynamic of Psychedelic States
- The shifting fortunes of corporate psychedelia
- Predictors and potentiators of psychedelic-occasioned mystical experiences
- A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations
- Chaplains in Psychedelic Assisted Therapy: Rationale and Competencies
- Psychedelic therapies and belief change: are there risks of epistemic harm or epistemic injustice?
- Ten new species of Inocybe ( Inocybaceae, Agaricales ) from the Gaoligong Mountains, southwestern China
- Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners
- Peak Experiences Matter
- The phenomenology of psilocybin: transformative insights for research and clinical practice
- Psychedelics and environmental virtues
- Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
- Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial
- With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis
- Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts
- Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
- The hidden therapist: evidence for a central role of music in psychedelic therapy
- Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults
- The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health
- Human hallucinogen research: guidelines for safety
- Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications
- Psychedelics not linked to mental health problems or suicidal behavior: A population study
- Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial
- How do psychedelics work?
- Psychedelics Align Brain Activity with Context
- Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
- Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans
- Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
- Integration of personal psychedelic experiences into clinical practice: A phenomenological study in mental health professionals
- Psilocybin desynchronizes the human brain
- Models of psychedelic drug action: modulation of cortical-subcortical circuits
- Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
- Quantitative Analysis of Narrative Reports of Psychedelic Drugs
- Brain mechanisms in religion and spirituality: An integrative predictive processing framework
- Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner
- Tripping on nothing: placebo psychedelics and contextual factors
- Effect of Hallucinogens on Unconditioned Behavior
- The Near-Death Experience Content (NDE-C) scale: Development and psychometric validation
- From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner
- DETERMINATION OF RADIOACTIVE IODINE IN PLANTS.
- Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
- The behavioral pharmacology of hallucinogens
- Psychedelics Promote Structural and Functional Neural Plasticity
- DMT Models the Near-Death Experience
- Neuropharmacology of N,N-dimethyltryptamine
- Psychoactive Substances and Paranormal Phenomena: A Comprehensive Review
- Serotonin and serotonin receptors in hallucinogen action
- PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS
- Psychedelics, Meditation, and Self-Consciousness
- The Nondual Awareness Dimensional Assessment (NADA): New tools to assess nondual traits and states of consciousness occurring within and beyond the context of meditation.
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
- Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis
- Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology
- The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women
- Mushroom [wikipedia]
- Human hallucinogen research: guidelines for safety. [europepmc]
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. [europepmc]
- Psychometric evaluation of the altered states of consciousness rating scale (OAV). [europepmc]
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. [europepmc]
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. [europepmc]
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. [europepmc]
- Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. [europepmc]
- Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. [europepmc]
- Broadband cortical desynchronization underlies the human psychedelic state. [europepmc]
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. [europepmc]
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. [europepmc]
- Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. [europepmc]
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. [europepmc]
- Long-term follow-up of psilocybin-facilitated smoking cessation. [europepmc]
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. [europepmc]
- The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. [europepmc]
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. [europepmc]
- Psychedelics Promote Structural and Functional Neural Plasticity. [europepmc]
- Predicting Responses to Psychedelics: A Prospective Study. [europepmc]
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. [europepmc]
- Emotions and brain function are altered up to one month after a single high dose of psilocybin. [europepmc]
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. [europepmc]
- The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects. [europepmc]
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. [europepmc]
- The neural basis of psychedelic action. [europepmc]